{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:11:23Z","timestamp":1787235083658,"version":"build-2736575974"},"reference-count":90,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Atypical parkinsonian syndromes (APSs) are a group of neurodegenerative disorders that differ from idiopathic Parkinson\u2019s disease (IPD) in their clinical presentation, underlying pathology, and response to treatment. APSs include conditions such as multiple system atrophy (MSA), progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and dementia with Lewy bodies (DLB). These disorders are characterized by a combination of parkinsonian features and additional symptoms, such as autonomic dysfunction, supranuclear gaze palsy, and asymmetric motor symptoms. Many hypotheses attempt to explain the causes of neurodegeneration in APSs, including interactions between environmental toxins, tau or \u03b1-synuclein pathology, oxidative stress, microglial activation, and vascular factors. While extensive research has been conducted on APSs, there is a limited understanding of the symmetry in these diseases, particularly in MSA. Neuroimaging studies have revealed metabolic, structural, and functional abnormalities that contribute to the asymmetry in APSs. The asymmetry in CBS is possibly caused by a variable reduction in striatal D2 receptor binding, as demonstrated in single-photon emission computed tomography (SPECT) examinations, which may explain the disease\u2019s asymmetric manifestation and poor response to dopaminergic therapy. In PSP, clinical dysfunction correlates with white matter tract degeneration in the superior cerebellar peduncles and corpus callosum. MSA often involves atrophy in the pons, putamen, and cerebellum, with clinical symmetry potentially depending on the symmetry of the atrophy. The aim of this review is to present the study findings on potential symmetry as a tool for determining potential neuropsychological disturbances and properly diagnosing APSs to lessen the misdiagnosis rate. Methods: A comprehensive review of the academic literature was conducted using the medical literature available in PubMed. Appropriate studies were evaluated and examined based on patient characteristics and clinical and imaging examination outcomes in the context of potential asymmetry. Results: Among over 1000 patients whose data were collected, PSP-RS was symmetrical in approximately 84% \u00b1 3% of cases, with S-CBD showing similar results. PSP-P was symmetrical in about 53\u201355% of cases, while PSP-CBS was symmetrical in fewer than half of the cases. MSA-C was symmetrical in around 40% of cases. It appears that MSA-P exhibits symmetry in about 15\u201335% of cases. CBS, according to the criteria, is a disease with an asymmetrical clinical presentation in 90\u201399% of cases. Similar results were obtained via imaging methods, but transcranial sonography produced different results. Conclusions: Determining neurodegeneration symmetry may help identify functional deficits and improve diagnostic accuracy. Patients with significant asymmetry in neurodegeneration may exhibit different neuropsychological symptoms based on their individual brain lateralization, impacting their cognitive functioning and quality of life.<\/jats:p>","DOI":"10.3390\/jcm13195798","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T06:39:35Z","timestamp":1727678375000},"page":"5798","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Asymmetry in Atypical Parkinsonian Syndromes\u2014A Review"],"prefix":"10.3390","volume":"13","author":[{"given":"Patryk","family":"Chunowski","sequence":"first","affiliation":[{"name":"Department of Neurology, Medical University of Warsaw, 03-242 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8685-475X","authenticated-orcid":false,"given":"Natalia","family":"Madetko-Alster","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Warsaw, 03-242 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5371-6817","authenticated-orcid":false,"given":"Piotr","family":"Alster","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Warsaw, 03-242 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"key":"ref_1","first-page":"61","article-title":"The Differential Diagnosis and Treatment of Atypical Parkinsonism","volume":"113","author":"Levin","year":"2016","journal-title":"Dtsch. Aerztebl. Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/tcmj.tcmj_218_20","article-title":"Epidemiology of atypical parkinsonian syndromes","volume":"34","author":"Lo","year":"2022","journal-title":"Tzu Chi Med. J."},{"key":"ref_3","unstructured":"Vertes, A.C., Beato, M.R., Sonne, J., and Khan Suheb, M.Z. (2024). Parkinson-Plus Syndrome, StatPearls Publishing."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1212\/01.WNL.0000165960.04422.D0","article-title":"New Reliab. MRI Diagn. Progress. Supranuclear Palsy","volume":"64","author":"Oba","year":"2005","journal-title":"Neurology"},{"key":"ref_5","first-page":"165","article-title":"Parkinson\u2019s Disease Society Brain Bank, London: Overview and Research","volume":"39","author":"Daniel","year":"1993","journal-title":"J. Neural Transm. Suppl."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/jcsm.13312","article-title":"Impaired skeletal muscle health in Parkinsonian syndromes: Clinical implications, mechanisms and potential treatments","volume":"14","author":"Murphy","year":"2023","journal-title":"J. Cachex Sarcopenia Muscle"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.29005","article-title":"The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy","volume":"37","author":"Wenning","year":"2022","journal-title":"Mov. Disord."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria","volume":"32","author":"Respondek","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: Clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/mds.28406","article-title":"Is Levodopa Response a Valid Indicator of Parkinson\u2019s Disease?","volume":"36","author":"Martin","year":"2021","journal-title":"Mov. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.parkreldis.2017.06.017","article-title":"Neurophysiological studies on atypical parkinsonian syndromes","volume":"42","author":"Bologna","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2013.06.032","article-title":"Update on diffusion MRI in Parkinson\u2019s disease and atypical parkinsonism","volume":"332","author":"Meijer","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Talai, A.S., Sedlacik, J., Boelmans, K., and Forkert, N.D. (2021). Utility of Multi-Modal MRI for Differentiating of Parkinson\u2019s Disease and Progressive Supranuclear Palsy Using Machine Learning. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.648548"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/brain\/awz189","article-title":"Improving diagnostic accuracy of multiple system atrophy: A clinicopathological study","volume":"142","author":"Miki","year":"2019","journal-title":"Brain"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s41380-022-01875-2","article-title":"Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer\u2019s disease, corticobasal degeneration and progressive supranuclear palsy brains","volume":"28","author":"Malarte","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Liu, Z., and Cheung, H.-H. (2020). Stem Cell-Based Therapies for Parkinson Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218060"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e01700","DOI":"10.1002\/brb3.1700","article-title":"Parkinson\u2019s disease or atypical parkinsonism? The importance of acoustic voice analysis in differential diagnosis of speech disorders","volume":"10","author":"Friedman","year":"2020","journal-title":"Brain Behav."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"ref_20","first-page":"61","article-title":"Phenotypic Variants of Patients with Progressive Supranuclear Palsy","volume":"57","author":"Gultekin","year":"2020","journal-title":"Noro Psikiyatr. Ars."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1007\/s10072-022-05919-x","article-title":"Uncovering clinical and radiological asymmetry in progressive supranuclear palsy\u2014Richardson\u2019s syndrome","volume":"43","author":"Picillo","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/aian.AIAN_611_20","article-title":"Subtypes of PSP and prognosis: A retrospective analysis","volume":"24","author":"Kishore","year":"2021","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.parkreldis.2009.11.013","article-title":"Symmetric corticobasal degeneration (S-CBD)","volume":"16","author":"Hassan","year":"2010","journal-title":"Park. Relat. Disord."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1007\/s00415-021-10522-9","article-title":"Diagnostic value of video-oculography in progressive supranuclear palsy: A controlled study in 100 patients","volume":"268","author":"Wunderlich","year":"2021","journal-title":"J. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/mdc3.12756","article-title":"Asymmetric Limb Dystonia in Progressive Supranuclear Palsy: Conundrum in Nosology","volume":"6","author":"Stezin","year":"2019","journal-title":"Mov. Disord. Clin. Pr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/RLU.0000000000000373","article-title":"Neuronal Correlates of Clinical Asymmetry in Progressive Supranuclear Palsy","volume":"39","author":"Amtage","year":"2014","journal-title":"Clin. Nucl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.3346\/jkms.2022.37.e183","article-title":"A Case of Pathologically Confirmed Corticobasal Degeneration Initially Presenting as Progressive Supranuclear Palsy Syndrome","volume":"37","author":"Chung","year":"2022","journal-title":"J. Korean Med. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/ane.12067","article-title":"Differentiation of Progressive Supranuclear Palsy: Clinical, imaging and laboratory tools","volume":"127","author":"Liscic","year":"2013","journal-title":"Acta Neurol. Scand."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1093\/brain\/awr234","article-title":"Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome","volume":"134","author":"Kouri","year":"2011","journal-title":"Brain"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1093\/brain\/awu256","article-title":"A disease-specific metabolic brain network associated with corticobasal degeneration","volume":"137","author":"Niethammer","year":"2014","journal-title":"Brain"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1002\/mds.21714","article-title":"Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson\u2019s disease","volume":"22","author":"Kwon","year":"2007","journal-title":"Mov. Disord."},{"key":"ref_32","first-page":"384","article-title":"Dom, RDual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis","volume":"47","author":"Casteels","year":"2006","journal-title":"J. Nucl. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mdc3.13091","article-title":"Utility of Imaging of Nigrosome-1 on 3T MRI and Its Comparison with 18F-DOPA PET in the Diagnosis of Idiopathic Parkinson Disease and Atypical Parkinsonism","volume":"8","author":"Kathuria","year":"2020","journal-title":"Mov. Disord. Clin. Pr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1098\/rsbl.2003.0092","article-title":"Handedness frequency over more than ten thousand years","volume":"271","author":"Faurie","year":"2004","journal-title":"Proc. R. Soc. B Biol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"119040","DOI":"10.1016\/j.neuroimage.2022.119040","article-title":"Large-scale differences in functional organization of left- and right-handed individuals using whole-brain, data-driven analysis of connectivity","volume":"252","author":"Tejavibulya","year":"2022","journal-title":"Neuroimage"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hbm.21247","article-title":"Cerebral lateralization of praxis in right- and left-handedness: Same pattern, different strength","volume":"33","author":"Vingerhoets","year":"2012","journal-title":"Hum. Brain Mapp."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-510X(03)00014-5","article-title":"Study of the rostral midbrain atrophy in progressive supranuclear palsy","volume":"210","author":"Kato","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2463\/mrms.3.125","article-title":"Morning Glory Sign: A Particular MR Finding in Progressive Supranuclear Palsy","volume":"3","author":"Adachi","year":"2004","journal-title":"Magn. Reson. Med Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/mds.26813","article-title":"Increased basal ganglia binding of 18F-AV-1451 in patients with progressive supranuclear palsy","volume":"32","author":"Smith","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.parkreldis.2011.10.013","article-title":"Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: Determining sample size for treatment trials","volume":"18","author":"Whitwell","year":"2011","journal-title":"Park. Relat. Disord."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Bopp, M.H.A., Emde, J., Carl, B., Nimsky, C., and Sa\u00df, B. (2021). Diffusion Kurtosis Imaging Fiber Tractography of Major White Matter Tracts in Neurosurgery. Brain Sci., 11.","DOI":"10.3390\/brainsci11030381"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.11138\/FNeur\/2017.32.4.201","article-title":"Apathy in corticobasal degeneration: Possible parietal involvement","volume":"22","author":"Moretti","year":"2017","journal-title":"Funct. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00415-019-09555-y","article-title":"Cognitive impairment and structural brain damage in multiple system atrophy-parkinsonian variant","volume":"267","author":"Caso","year":"2019","journal-title":"J. Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.parkreldis.2014.01.023","article-title":"Diffusion tensor imaging comparison of progressive supranuclear palsy and corticobasal syndromes","volume":"20","author":"Whitwell","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41582-021-00541-5","article-title":"Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies","volume":"17","author":"Stamelou","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/jnnp-2021-328586","article-title":"Neuropathology and emerging biomarkers in corticobasal syndrome","volume":"93","author":"Koga","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/B978-0-12-804766-8.00012-1","article-title":"Neuroimaging in aging and neurologic diseases","volume":"167","author":"Risacher","year":"2019","journal-title":"Handb Clin Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.irn.2018.08.010","article-title":"Structural Imaging in Atypical Parkinsonism","volume":"142","author":"Heim","year":"2018","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00429-022-02520-y","article-title":"Action goals and the praxis network: An fMRI study","volume":"227","author":"Michalowski","year":"2022","journal-title":"Brain Struct. Funct."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/neup.12745","article-title":"The hot cross bun sign in corticobasal degeneration","volume":"41","author":"Ando","year":"2021","journal-title":"Neuropathology"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Liu, M., Ren, H., Lin, N., Tan, Y., Fan, S., and Guan, H. (2022). The \u201chot cross bun sign\u201d in patients with autoimmune cerebellar ataxia: A case report and literature review. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.979203"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jnnp-2014-309645","article-title":"MRI signs of multiple system atrophy preceding the clinical diagnosis: The case for an imaging-supported probable MSA diagnostic category","volume":"87","author":"Mestre","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_53","unstructured":"Ghandili, M., and Munakomi, S. (2024). Neuroanatomy, Putamen, StatPearls Publishing."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1007\/s00429-017-1450-y","article-title":"The role of the putamen in language: A meta-analytic connectivity modeling study","volume":"222","author":"Wu","year":"2017","journal-title":"Brain Struct. Funct."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1016\/j.radcr.2023.05.060","article-title":"Asymmetrical putaminal atrophy in parkinsonism-predominant multiple system atrophy (MSA-P): A case report","volume":"18","author":"Mori","year":"2023","journal-title":"Radiol. Case Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s10072-023-06628-9","article-title":"Dopamine transporter SPECT imaging in Parkinson\u2019s disease and atypical Parkinsonism: A study of 137 patients","volume":"44","author":"Constantinides","year":"2023","journal-title":"Neurol. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/s00259-016-3464-8","article-title":"A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism","volume":"43","author":"Niccolini","year":"2016","journal-title":"Eur. J. Nucl. Med."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Shigekiyo, T., and Arawaka, S. (2020). Laterality of specific binding ratios on DAT-SPECT for differential diagnosis of degenerative parkinsonian syndromes. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-72321-y"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1210220","DOI":"10.3389\/fneur.2023.1210220","article-title":"Diagnosing multiple system atrophy: Current clinical guidance and emerging molecular biomarkers","volume":"14","author":"Goolla","year":"2023","journal-title":"Front Neurol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/1531-8257(200011)15:6<1158::AID-MDS1015>3.0.CO;2-0","article-title":"[123I]\u03b2-CIT spect in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration","volume":"15","author":"Pirker","year":"2000","journal-title":"Mov. Disord."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"107260","DOI":"10.1016\/j.neuropsychologia.2019.107260","article-title":"Differential involvement of left and right frontoparietal areas in visuospatial planning: An rTMS study","volume":"136","author":"Basso","year":"2020","journal-title":"Neuropsychologia"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00234-007-0265-6","article-title":"Imaging of corticobasal degeneration syndrome","volume":"49","author":"Koyama","year":"2007","journal-title":"Neuroradiology"},{"key":"ref_63","first-page":"701-e52","article-title":"Corticobasal syndrome: Neuroimaging and neurophysiological advances","volume":"26","author":"Suppa","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1017\/S135561770397010X","article-title":"Left and right basal ganglia and frontal activity during language generation: Contributions to lexical, semantic, and phonological processes","volume":"9","author":"Crosson","year":"2003","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/WNP.0000000000000377","article-title":"Structure and Function of the Human Insula","volume":"34","author":"Uddin","year":"2017","journal-title":"J. Clin. Neurophysiol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Seiffert, A.P., G\u00f3mez-Grande, A., Alonso-G\u00f3mez, L., M\u00e9ndez-Guerrero, A., Villarejo-Galende, A., G\u00f3mez, E.J., and S\u00e1nchez-Gonz\u00e1lez, P. (2023). Differences in Striatal Metabolism in [18F]FDG PET in Parkinson\u2019s Disease and Atypical Parkinsonism. Diagnostics, 13.","DOI":"10.3390\/diagnostics13010006"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1007\/s10072-022-06166-w","article-title":"FDG PET in the differential diagnosis of degenerative parkinsonian disorders: Usefulness of voxel-based analysis in clinical practice","volume":"43","author":"Arnone","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1021\/acschemneuro.3c00437","article-title":"Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R\/4R Tau Protofibrils","volume":"14","author":"Li","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Beyer, L., Meyer-Wilmes, J., Sch\u00f6necker, S., Schnabel, J., Brendel, E., Prix, C., N\u00fcbling, G., Unterrainer, M., Albert, N.L., and Pogarell, O. (2018). Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?. Front. Neurol., 9.","DOI":"10.3389\/fneur.2018.00483"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Alster, P., Madetko, N.K., Koziorowski, D.M., Kr\u00f3licki, L., Budrewicz, S., and Friedman, A. (2019). Accumulation of Tau Protein, Metabolism and Perfusion-Application and Efficacy of Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) Imaging in the Examination of Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS). Front. Neurol., 14.","DOI":"10.3389\/fneur.2019.00101"},{"key":"ref_71","first-page":"197","article-title":"Positron emission tomography in oncology with use of radiotracers alternative to 18F-fluorodeoxyglucose","volume":"9","author":"Szurowska","year":"2013","journal-title":"Oncol. Clin. Pract."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3906\/sag-2008-253","article-title":"Dopamine transporter SPECT imaging in Parkinson\u2019s disease and parkinsonian disorders","volume":"51","author":"Akdemir","year":"2021","journal-title":"Turk. J. Med Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00702-006-0536-0","article-title":"Characterization of dopaminergic dysfunction in familial progressive supranuclear palsy: An 18F-dopa PET study","volume":"114","author":"Tai","year":"2006","journal-title":"J. Neural Transm."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0022-510X(96)00057-3","article-title":"PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration","volume":"139","author":"Nagasawa","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s11682-023-00789-z","article-title":"[18F]-FDopa positron emission tomography imaging in corticobasal syndrome","volume":"17","author":"Giordana","year":"2023","journal-title":"Brain Imaging Behav."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Xian, W.B., Shi, X.C., Luo, G.H., Yi, C., Zhang, X.S., and Pei, Z. (2021). Co-registration Analysis of Fluorodopa and Fluorodeoxyglucose Positron Emission Tomography for Differentiating Multiple System Atrophy Parkinsonism Type from Parkinson\u2019s Disease. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.648531"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4103\/aian.AIAN_54_21","article-title":"Evaluation of Multiple System Atrophy Subtypes with FDG-PET","volume":"24","author":"Jellinger","year":"2021","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"108074","DOI":"10.1016\/j.clineuro.2023.108074","article-title":"Transcranial sonography in neurodegeneration with brain iron accumulation disorders","volume":"236","author":"Habibi","year":"2024","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_79","first-page":"51","article-title":"Ultrasonografia przezczaszkowa w diagnostyce parkinsonizmu","volume":"11","year":"2015","journal-title":"Pol. Przegl\u0105d Neurol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.parkreldis.2019.09.032","article-title":"Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study","volume":"68","author":"Moreno","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10072-023-07107-x","article-title":"Differentiating progressive supranuclear palsy from other movement disorders using transcranial sonography: A systematic review and meta-analysis","volume":"45","author":"Wen","year":"2023","journal-title":"Neurol. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/mds.22981","article-title":"Substantia nigra echogenicity in progressive supranuclear palsy","volume":"25","author":"Ebentheuer","year":"2010","journal-title":"Mov. Disord."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ultrasmedbio.2022.10.019","article-title":"Quantitative Transcranial Sonography Evaluation of Substantia Nigra Hyperechogenicity Is Useful for Predicting Levodopa-Induced Dyskinesia in Parkinson Disease","volume":"49","author":"Yan","year":"2023","journal-title":"Ultrasound Med. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Koziorowski, D., Figura, M., Milanowski, \u0141.M., Szlufik, S., Alster, P., Madetko, N., and Friedman, A. (2021). Mechanisms of Neurodegeneration in Various Forms of Parkinsonism\u2014Similarities and Differences. Cells, 10.","DOI":"10.3390\/cells10030656"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Dunalska, A., Pikul, J., Schok, K., Wiejak, K.A., and Alster, P. (2021). The Significance of Vascular Pathogenesis in the Examination of Corticobasal Syndrome. Front. Aging Neurosci., 4.","DOI":"10.3389\/fnagi.2021.668614"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneurol.2011.107","article-title":"Clinical correlates of white matter tract degeneration in progressive supranuclear palsy","volume":"68","author":"Whitwell","year":"2011","journal-title":"Arch. Neurol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Saito, Y., Kamagata, K., Wijeratne, P.A., Andica, C., Uchida, W., Takabayashi, K., Fujita, S., Akashi, T., Wada, A., and Shimoji, K. (2022). Temporal Progression Patterns of Brain Atrophy in Corticobasal Syndrome and Progressive Supranuclear Palsy Revealed by Subtype and Stage Inference (SuStaIn). Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.814768"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40478-019-0730-6","article-title":"Understanding the pathogenesis of multiple system atrophy: State of the art and future perspectives","volume":"7","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/pn-2020-002797","article-title":"Multiple system atrophy","volume":"23","author":"Goh","year":"2023","journal-title":"Pract Neurol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"106065","DOI":"10.1016\/j.parkreldis.2024.106065","article-title":"\"Advanced\" Parkinson\u2019s disease: A review","volume":"123","author":"Aslam","year":"2024","journal-title":"Park. Relat. Disord."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/19\/5798\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:05:53Z","timestamp":1760112353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/19\/5798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":90,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["jcm13195798"],"URL":"https:\/\/doi.org\/10.3390\/jcm13195798","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]}}}